Form:	DCIS Team Project Outcomes v1.0

CDE ID	CDE Description
* 2777	Site participant ID (Go To: 422)
* 422	EDRN Site ID (Go To: 423)
* 423	EDRN Protocol ID (Go To: 929)
* 929	EDRN Staff ID of the person who collected the data: (Go To: 1219)
* 1219	Date of contact (MM/DD/YYYY): (Go To: 2636)
* 2636	Diagnosed with DCIS? (Go To: 2823)
	Permissible Values (value): No (0)
	Yes (1) (Go To: 3144)
	N/A (98)
	Unknown (99)
* 3144	Number of loops: (Go To: 3200)
	Permissible Values (value): 0 (0)
	1 (1)
	2 (2)
	3 (3)
	4 (4)
* 3200	Line number or identifier (system-generated): (Go To: 3417)
* 3417	Timing of DCIS diagnosis: (Go To: 3403)
	Permissible Values (value): Recurrence of first primary diagnosis (2)
	Second primary diagnosis (3)
	Recurrence of second primary diagnosis (4)
* 3403	DCIS diagnosis date (MM/YYYY): (Go To: 1658)
* 1658	Pathologic primary DCIS tumor size (cm): (Go To: 2823)
* 2823	Diagnosed with breast cancer? (Go To: 1425)
	Permissible Values (value): No (0)
	Yes (1) (Go To: 1333)
	Unknown (99)
* 1333	Date of diagnosis (MM/YYYY): (Go To: 3371)
* 3371	Site of breast condition: (Go To: 3389)
	Permissible Values (value): Left breast (1)
	Right breast (2)
	Bilateral (5)
	Other, specify: (97) (Go To: 3399)
	Unknown (99)
* 3399	Site of invasive breast cancer (Other, specify): (Go To: 3389)
* 3389	Breast quadrant(s) of disease: (Go To: 3388)
	Permissible Values (value): Upper inner (1)
	Upper outer (2)
	Lower inner (3)
	Lower outer (4)
	12:00 (5)
	3:00 (6)
	6:00 (7)
	9:00 (9)
	Central (10)
	Other (95)
	Unknown (99)
* 3388	Is pathology available? (Go To: 1425)
	Permissible Values (value): No (0)
	Yes (1) (Go To: 1643)
	Unknown (99)
* 1643	Histological type (breast): (Go To: 3375)
	Permissible Values (value): Adenoid Cystic (1)
	Cribriform (3)
	Ductal (4)
	Lobular (5)
	Papillary (6)
	Micropapillary (7)
	Metaplastic (8)
	Medullary (10)
	Mucinous (colloid) (11)
	Malignant phyllodes tumor (12)
	Tubular (13)
	Apocrine (14)
	Ductal/Lobular (15)
	Mixed, specify: (16) (Go To: 3416)
	Other, specify: (97) (Go To: 1644)
	Unknown (99)
* 3416	Breast histological type; mixed, specify: (Go To: 3375)
* 1644	Histological type, other specify (breast): (Go To: 3375)
* 3375	Tumor grade: (Go To: 1675)
	Permissible Values (value): Low grade (well differentiated) (1)
	Intermediate grade (moderately differentiated) (2)
	High grade (poorly differentiated) (3)
	High grade (undifferentiated) (4)
	Unknown (99)
* 1675	Final estrogen receptor status diagnosis: (Go To: 1680)
	Permissible Values (value): Positive (1)
	Negative (2)
	Indeterminate (7)
	Unknown (99)
* 1680	Final progesterone receptor status diagnosis: (Go To: 1685)
	Permissible Values (value): Positive (1)
	Negative (2)
	Indeterminate (7)
	Unknown (99)
* 1685	Final diagnosis with HER2/neu: (Go To: 1703)
	Permissible Values (value): Positive (1)
	Negative (2)
	Equivocal (3)
	Unknown (99)
* 1703	Pathologic primary invasive tumor size (cm): (Go To: 1687)
* 1687	Total number of lymph nodes examined : (Go To: 2462)
* 2462	Number of positive nodes: (Go To: 1425)
* 1425	Is participant alive? (Go To: 3409)
	Permissible Values (value): No (0) (Go To: 3408)
	Yes (1)
	Unknown (99)
* 3408	Date of death (MM/YYYY): (Go To: 1097)
* 3409	Date of last contact (MM/YYYY): (Go To: 1097)
1097	Comments (do not include any participant identifiers) (Go To: End of Form)